Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
13.25
-0.11 (-0.85%)
At close: Feb 25, 2026
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $21.28 million as of March 6, 2026. Its market cap has increased by 12.29% in one year.
Market Cap
21.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.25
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 21.28M, a decrease of -97.88%. That is a compound annual growth rate of -54.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 21.28M | -1.76% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 22.06M |
| EOM Pharmaceuticals Holdings | 20.24M |
| Oncotelic Therapeutics | 18.82M |
| Anebulo Pharmaceuticals | 17.95M |
| Inhibitor Therapeutics | 17.43M |
| NKGen Biotech | 26.12M |
| Zeo ScientifiX | 14.88M |
| Harvard Apparatus Regenerative Technology | 30.77M |